Loading...
XSAU
4009
Market cap1.08bUSD
Nov 12, Last price  
43.96SAR
Name

Middle East Healthcare Company SJSC

Chart & Performance

D1W1MN
XSAU:4009 chart
P/E
13.40
P/S
1.30
EPS
3.28
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
11.85%
Revenues
3.10b
+7.62%
542,221,996828,359,8601,398,751,6121,534,527,9761,615,641,1541,629,429,6071,390,690,3931,496,646,9131,772,209,6161,872,620,7902,151,743,7362,653,170,4752,882,818,0003,102,630,000
Net income
302m
+7.05%
61,994,012137,197,859331,969,205390,249,302361,860,047300,082,828172,249,37197,568,34781,992,57211,732,48675,182,816180,176,414282,002,000301,880,000
CFO
355m
-53.60%
-2,430,724128,505,012349,281,631193,996,071257,303,609340,637,928161,355,86098,638,314-263,389,19376,621,68576,023,275191,083,162766,001,000355,395,487
Dividend
Jul 09, 20250.5 SAR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Middle East Healthcare Company is a prominent medical service provider that manages and operates an extensive network of Saudi German Hospitals throughout the Middle East and North Africa region. These facilities offer comprehensive multi-specialty tertiary care. The company's diverse hospital portfolio includes Saudi German Hospital-Jeddah with 218 beds, Saudi German Hospital-Aseer featuring 400 beds, Saudi German Hospital-Riyadh and Saudi German Hospital-Madinah each equipped with 300 beds, and Saudi German Hospital-Hail providing 150 beds. Expanding its reach further, the network also encompasses Saudi German Hospital-Dammam, offering 150 to 300 beds; Saudi German Hospital-Sanaa and Saudi German Hospital-Dubai, both with 300 beds; Saudi German Hospital-Sharjah, a 50-bed facility; Saudi German Hospital-Ajman, which has between 100 and 200 beds; and Saudi German Hospital-Cairo, accommodating 332 patients. Established in 1988, the company's primary corporate base is situated in Jeddah, Kingdom of Saudi Arabia.
URL
IPO date
Mar 29, 2016
Employees
Domiciled in
SA
Incorporated in
SA

Valuation

Title
SAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT